New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2727-2731

  Hulten K ^a   Rigo, R ^a   Gustafsson, I ^a   Engstrand, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLARITHROMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL TYPE; DRUG EFFECT; DRUG HALF LIFE; DUODENUM ULCER; EPITHELIUM CELL; EXTRACELLULAR FLUID; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INTERNALIZATION; PRIORITY JOURNAL;

EID: 0029847104     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2727     Document Type: Article

References (35)

1. Anderson, R., G. Joone, and C. E. van Rensburg. 1986. An in vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin, and erythromycin for Staphylococcus aureus. J. Infect. Dis. 153:593-600.
2. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, G. Alampi, P. Simoni, S. Sottili, A. Roda, and E. Roda. 1995. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6:773-777.
3. Berry, V., K. Jennings, and G. Woodnutt. 1995. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob. Agents Chemother. 39:1859-1861.
4. Blaser, J., B. B Stone, and S. H. Zinner. 1985. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob. Agents Chemother. 27:343-344.
5. Chippendale, G. R., J. W. Warren, A. L. Trifillis, and H. L. T. Mobley. 1994. Internalization of Proteus mirabilis by human renal epithelial cells. Infect. Immun. 62:3115-3121.
6. Cooper, M. A., K. Nye, J. M. Andrews, and R. Wise. 1990. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin. J. Antimicrob. Chemother. 26:533-538.
7. Croydon, E. A. P., and R. Sutherland. 1971. α-Amino-ρ-hydroxyhensylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and secretion in man, p. 427-430. Antimicrob. Agents Chemother. 1970.
8. Darouiche, R. O., and R. J. Hamill. 1994. Antibiotic penetration of and bactericidal activity within endothelial cells. Antimicrob. Agents Chemother. 38:1059-1064.
9. Evans, D. G., D. Evans, Jr., and D. Y. Graham. 1992. Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology. 102: 1557-1567.
10. Finlay, B. B., K. Y. Leung, I. Rosenshine, and F. Garcia-del Portillo. 1992. Salmonella interactions with the epithelial cell. ASM News 58:486-489.
11. Forsgren, J., A. Samuelson, A. Ahlin, J. Jonasson, B. Rynnel-Dagöö, and A. Lindberg. 1994. Haemophilus influenzae resides and multiples intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect. Immun. 62:673-679.
12. Gaillard, J. 1987. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect. Immun. 55:2822-2829.
13. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-82.
14. Gordon, R. C., C. Regamey, and W. M. M. Kirby. 1972. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob. Agents Chemother. 1:504-507.
15. Holmes, B., P. G. Quie, D. B. Windhorst, B. Pollara, and R. A. Good. 1966. Protection of phagocytized bacteria from the killing action of antibiotics. Nature (London) 210:1131-1132.
16. Hultén, K., O. Cars, E. Hjelm, and L. Engstrand. 1996. In vitro activity of azithromycin against intracellular Helicobacter pylori. J. Antimicrob. Chemother. 37:483-489.
17. Jaup, B. H., and A. Norrby. 1994. Low dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am. J. Gastroenterol. 90:943-945.
18. Konkel, M. E., and L. A. Joens. 1989. Adhesion to and invasion of HEp-2 cells by Campylobacter spp. Infect. Immun. 57:2984-2990.
19. Labenz, J., M. Stolte, A. L. Blum, I. Jorias, F. Leverkus, M. Sollbohmer, J. Bertrams, and G. Borsch. 1995. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 37:39-43.
20. Laine, L., C. Stein, and G. Neil. 1995. Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimaldosing. Am. J. Gastroenterol. 90:1407-10.
21. Lode, H., P. Janisch, G. Küpper, and H. Weuta. 1974. Comparative clinical pharmacology of three ampicillins and amoxicillin administered orally. J. Infect. Dis. 129(Suppl.):S156-168.
22. Löwdin, E., I. Odenholt, and O. Cars. 1995. Pharmacokinetic studies of vancomycin against S. aureus and S. epidermidis in an in vitro kinetic model, abstr. 100. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Meyer, A. P., C. Bril-Bazuin, H. Mattie, and P. J. van den Broek. 1993. Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. Antimicrob. Agents Chemother. 37:2318-2322.
24. Moulder, J. W. 1985. Comparative biology of intracellular parasitism. Microbiol. Rev. 49:298-337.
25. Murakawa, T., H. Sakamoto, T. Hirose, and M. Nishida. 1980. New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics. Antimicrob. Agents Chemother. 18:377-381.
26. Neu, H. C. 1974. Antimicrobial activity and human pharmacology of amoxicillin. J. Infect. Dis. 129(Suppl.):S123-128.
27. Neu, H. C., and E. B. Winshell. 1971. Pharmacological studies of 6 |D(-)α-amino-ρ-hydroxyphenylacetamido|penicillanic acid in humans, p. 423-426. Antimicrob. Agents Chemother. 1970.
28. Noach, L. A., T. M. Rolf, and G. N. J. Tytgat. 1994. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J. Clin. Pathol. 47:699-704.
29. Peters, D. H., H. A. Friedel, and D. McTavish. 1992. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 44:750-799.
30. Rous, P., and F. S. Jones. 1916. The protection of pathogenic organisms by living tissue cells. J. Exp. Med. 23:601-613.
31. Rubens, C. E., S. Smith, M. Hulse, E. Y. Chi, and G. van Belle. 1992. Respiratory epithelial cell invasion by group B streptococci. Infect. Immun. 60:5157-5163.
32. Scaglione, F., G. Demartini, S. Dugnani, and F. Fraschini. 1993. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. Chemotherapy 39:416-423.
33. Small, P. L., R. R. Isberg, and S. Falkow. 1987. Comparison of the ability of enteroinvasive Escherichia coli, Salmonella typhimurium, Yersinia pseudotuberculosis, and Yersinia enterocolitica to enter and replicate within HEp-2 cells. Infect. Immun. 55:1674-1679.
34. Tulkens, P. M. 1991. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 10:100-106.
35. Whitman, M. S., and A. R. Tunkel. 1992. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect. Control Hosp. Epidemiol. 13:357-368.